These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32155621)

  • 1. Neutrophil Gelatinase-Associated Lipocalin for the Early Prediction of Acute Kidney Injury in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
    Merdler I; Rozenfeld KL; Zahler D; Shtark M; Goldiner I; Loewenstein IS; Fortis L; Hochstadt A; Keren G; Banai S; Shacham Y
    Cardiorenal Med; 2020; 10(3):154-161. PubMed ID: 32155621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
    Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
    Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated neutrophil gelatinase-associated lipocalin levels before contrast media administration among ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Rozenfeld KL; Zahler D; Shtark M; Goldiner I; Keren G; Shacham Y
    Coron Artery Dis; 2020 Mar; 31(2):118-123. PubMed ID: 31145117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
    Zahler D; Rozenfeld KL; Merdler I; Peri Y; Shacham Y
    Cardiorenal Med; 2020; 10(2):108-115. PubMed ID: 31801134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil Gelatinase-Associated Lipocalin for the Assessment of Reversible versus Persistent Renal Tubular Damage in ST-Segment Myocardial Infarction Patients.
    Banai A; Rozenfeld KL; Loewenstein I; Zahler D; Shtark M; Goldiner I; Banai S; Shacham Y
    Blood Purif; 2021; 50(6):925-930. PubMed ID: 33756457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Neutrophil Gelatinase-Associated Lipocalin for the Assessment of Structural versus Functional Renal Damage among ST-Segment Elevation Myocardial Infarction Patients.
    Rozenfeld KL; Zahler D; Shtark M; Goldiner I; Keren G; Banai S; Shacham Y
    Blood Purif; 2020; 49(5):560-566. PubMed ID: 32074603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indexed neutrophil gelatinase associated lipocalin: a novel biomarker for the assessment of acute kidney injury.
    Frydman S; Freund O; Zornitzki L; Katash HA; Banai S; Shacham Y
    J Nephrol; 2024 Mar; 37(2):401-407. PubMed ID: 37917333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil gelatinase-associated lipocalin (NGAL) for the prediction of acute kidney injury in chronic kidney disease patients treated with primary percutaneous coronary intervention.
    Banai A; Rozenfeld KL; Levit D; Merdler I; Loewenstein I; Banai S; Shacham Y
    Int J Cardiol Heart Vasc; 2021 Feb; 32():100695. PubMed ID: 33364336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of Baseline Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Contrast-Induced Nephropathy following Percutaneous Coronary Intervention among Chronic Kidney Disease Patients.
    Lupu L; Abukatash H; Banai A; Rozenfeld KL; Lewit D; Merdler I; Loewenstein I; Bornstein G; Banai S; Shacham Y
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
    Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic correlates of left ventricular filling pressures and acute cardio-renal syndrome in ST segment elevation myocardial infarction patients.
    Flint N; Kaufman N; Gal-Oz A; Margolis G; Topilsky Y; Keren G; Shacham Y
    Clin Res Cardiol; 2017 Feb; 106(2):120-126. PubMed ID: 27550512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarction.
    Tung YC; Chang CH; Chen YC; Chu PH
    PLoS One; 2015; 10(4):e0125282. PubMed ID: 25853556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial measurements of neutrophil gelatinase-associated lipocalin: prognostic value in patients with ST-segment elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Lim YM; Moon JY; Min D; Kim SH; Yang WI; Kim WJ; Sung JH; Kim IJ; Lim SW; Cha DH
    Coron Artery Dis; 2017 Dec; 28(8):690-696. PubMed ID: 28737526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury based on the KDIGO criteria among ST elevation myocardial infarction patients treated by primary percutaneous intervention.
    Margolis G; Gal-Oz A; Letourneau-Shesaf S; Khoury S; Keren G; Shacham Y
    J Nephrol; 2018 Jun; 31(3):423-428. PubMed ID: 29185210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
    Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein velocity and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Zahler D; Rozenfeld KL; Stein M; Milwidsky A; Berliner S; Banai S; Arbel Y; Shacham Y
    J Nephrol; 2019 Jun; 32(3):437-443. PubMed ID: 30706372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of neutrophil Gelatinase associated Lipocalin (NGAL) predicts hemodialysis after coronary angiography in high risk patients with acute coronary syndrome.
    Reyes LF; Severiche-Bueno DF; Bustamante CA; Murillo S; Soni NJ; Poveda M; Gomez E; Buitrago R; Rodriguez A
    BMC Nephrol; 2020 Apr; 21(1):143. PubMed ID: 32321453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early diagnostic value of neutrophil gelatinase-associated lipocalin and interleukin-18 in patients with sepsis-induced acute kidney injury].
    Zhu L; Shi D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):718-22. PubMed ID: 27434563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma neutrophil gelatinase-associated lipocalin as a predictive biomarker for the detection of acute kidney injury in adult poisoning.
    Ahn JY; Lee MJ; Seo JS; Choi D; Park JB
    Clin Toxicol (Phila); 2016; 54(2):127-33. PubMed ID: 26683351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.